Heather Cox, President of Insights & Empowerment at Zelis, talked about the company’s care coordination tools with MedCity News Reporter Katie Adams. The post MedCity Pivot Podcast: Putting a Human Touch on Healthcare Navigation and Coordination appeared first on MedCity News.
Most health economists people know quality adjusted life years (QALYs) are. But why are they so widely used in the United Kingdom, but not in the United States? A paper by MacKillop and Sheard (2018) provides an interesting history of the QALY and is worth a read. For QALYs to be useful there first had…
NEW YORK — On a recent visit to Federal Plaza in Lower Manhattan, some floors in the mammoth office building bustled with people seeking services or facing legal proceedings at federal agencies such as the Social Security Administration and Immigration and Customs Enforcement. In the lobby, dozens of people took photos to celebrate becoming U.S….
Is a private-label product really better once you factor in performance, durability, and everything it takes to support it? Sometimes yes and sometimes no. The job is knowing the difference. The post Maximizing Value vs. Minimizing Cost in Healthcare Purchasing appeared first on MedCity News.
Gilead Sciences’ Tubulis acquisition brings antibody drug conjugates in clinical development for cancer. Analysts say the Tubulis platform technologies that yielded these ADCs could also help Gilead develop drugs in other therapeutic areas. The post Gilead’s Pipeline Strategy Takes Shape With $3B Acquisition of Cancer Biotech Tubulis appeared first on MedCity News.
Telehealth clinic Hone Health partnered with imaging company BodySpec to give its patients access to DEXA body composition scans. The partnership seeks to help providers and patients on GLP-1s distinguish fat loss from muscle loss and better evaluate how these drugs are affecting the body. The post Beyond the Scale: How Imaging Can Help Determine…
GSK said the mixed Phase 3 results for camlipixant mean this pill “is unlikely to transform patient care” in recurrent chronic cough. GSK is stopping work in this indication, a setback to a program once hoped to yield a new blockbuster product for the company’s respiratory drug portfolio. The post GSK Drug From $2B Deal…
The goal of MiHIN’s partnership with Beyond Lucid Technologies is to have seamless communication between ambulances and hospitals to streamline patient handoff
By MATTHEW HOLT Strap in for the tale of why your hero is spending most of his life down YouTube rabbit holes of cardiology videos while blundering his way around many many medical centers and exposing many problems with American health care even before he gets close to the operating table. Yes it’s Matthew Holt’s…
March has seen a slew of executive hires, exits and layoffs across the healthcare industry. For example, providers like Providence and Geisinger have appointed new C-suite leaders, and companies like Blue Shield of California and Evernorth have undergone CEO exits. There were also layoffs at organizations including HHS, Blue Cross of Idaho and the University…